Related by context. Frequent words. (Click for all words.) 69 Immune Globulin Intravenous 67 Receives Orphan Drug Designation 66 Xyntha 66 Application MAA 66 Initiates Phase II 66 ZALBIN 65 Urokinase 65 Recombinant Human 65 Rotarix R 64 Argatroban 64 Elan Pharma 64 Inc Therapeutic Competitors 64 BioGlue R 64 Eloxatin ® 63 Generic Version 63 Paladin Labs 63 Loramyc R 63 Eligard R 63 Release Tablets 62 Medicis Pharmaceutical Corporation 62 THALOMID 62 gets USFDA nod 62 Orphan Drug designation 62 topical anti infective 62 EFJohnson 3e Technologies 62 Therapeutic Competitors 62 Dynepo 62 Testim R 62 Nabi HB 62 Presents Positive 62 NASDAQ OSIR 62 Pivotal Phase III 61 NASDAQ CRXL 61 Advancing Drugs 61 Angiox 61 Ceftriaxone 61 R sorafenib tablets 61 MKC# 61 Portola Pharmaceuticals 61 FDA Accepts 61 SANCTURA R 61 Altus Pharmaceuticals 61 submitted Biologics License 61 commercialize telaprevir 61 Onalta 61 Surgical Adhesive 61 Ethyol 61 Nasdaq CRXL 61 Idera Pharmaceuticals 61 submitted Marketing Authorization 61 Rectogesic 61 Cetrorelix 61 Sanctura 61 Pharmion Corporation 61 GEM #S 60 ABILIFY R 60 Kuvan R 60 Aloxi R 60 Xanodyne Pharmaceuticals 60 EPIX Pharmaceuticals 60 Dificid 60 Thrombin 60 ONTAK 60 Meets Primary Endpoint 60 Anika Therapeutics 60 Medarex logo 60 Curosurf 60 Soliris TM eculizumab 60 Cerus Corporation 60 Drug Candidate 60 Clofarabine 60 Estrasorb 60 China Aoxing Pharmaceutical 60 Tibotec Pharmaceuticals Ltd. 60 EntreMed Inc. 60 Rebif ® 60 Eligard ® 60 Panzem R 60 New Chemical Entities 60 Vitaros ® 60 SCHWARZ PHARMA 59 AMRIX 59 Loramyc ® 59 Orphan Drug Status 59 Janssen Pharmaceutica NV 59 OMRIX 59 mesylate 59 Transcept Pharmaceuticals 59 Icatibant 59 Chiral Quest 59 Meda AB 59 Nexavar ® 59 BioDelivery Sciences 59 NEBIDO R 59 intravenous formulations 59 MuGard TM 59 Ore Pharmaceuticals 59 Par Pharmaceuticals 59 therapeutic monoclonal antibodies 59 Aradigm Corporation 59 BioMarin Genzyme LLC